• FirefoxInstall the new Firefox »
  •  Dow Down0.23% Nasdaq Down0.27%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    282.69 Up 22.05(8.46%) 4:00PM EDT
    |After Hours : 281.30 Down 1.39 (0.49%) 7:22PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,742   1,622   2,446  
    Cost of Revenue -   -   -  
    Gross Profit 1,742   1,622   2,446  
    Operating Expenses
    Research Development80,311  27,942  16,183  
    Selling General and Administrative34,601  13,132  5,177  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (113,170) (39,452) (18,914)
    Income from Continuing Operations
    Total Other Income/Expenses Net(170,056)(28,341)(24,729)
    Earnings Before Interest And Taxes(283,226)(67,792)(43,643)
    Interest Expense -   -   -  
    Income Before Tax(283,226)(67,792)(43,643)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(283,226)(67,792)(43,643)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (283,226) (67,792) (43,643)
    Preferred Stock And Other Adjustments -   -  (2,630)
    Net Income Applicable To Common Shares (283,226) (67,792) (46,274)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.